$2.77
1.95% today
Nasdaq, May 09, 06:01 pm CET
ISIN
IL0011326795
Symbol
PYPD
Sector
Industry

Polypid Ltd Stock price

$2.72
+0.29 11.93% 1M
-0.83 23.38% 6M
-0.32 10.53% YTD
-1.59 36.89% 1Y
-137.68 98.06% 3Y
-567.28 99.52% 5Y
-567.28 99.52% 10Y
Nasdaq, Closing price Thu, May 08 2025
-0.10 3.50%
ISIN
IL0011326795
Symbol
PYPD
Sector
Industry

Key metrics

Market capitalization $27.72m
Enterprise Value $21.53m
P/E (TTM) P/E ratio negative
P/B ratio (TTM) P/B ratio 3.61
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-28.03m
Cash position $15.81m
EPS (TTM) EPS $-4.98
Short interest 0.06%

Is Polypid Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,791 stocks worldwide.

Polypid Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Polypid Ltd forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Polypid Ltd forecast:

Buy
100%

Financial data from Polypid Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 5.22 5.22
22% 22%
-
- Research and Development Expense 23 23
41% 41%
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -28 -28
23% 23%
-
Net Profit -29 -29
22% 22%
-

In millions USD.

Don't miss a Thing! We will send you all news about Polypid Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Polypid Ltd Stock News

Neutral
GlobeNewsWire
10 days ago
PETACH TIKVA, Israel, April 29, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its first quarter 2025 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, May 14, 2025. The Company will host a conference c...
Neutral
GlobeNewsWire
17 days ago
PETACH TIKVA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Company's management will participate in a fireside chat at The Citizens Life Sciences Conference taking place in New York, NY, from May 7-8, 2025.
Neutral
GlobeNewsWire
about 2 months ago
PETACH TIKVA, Israel, March 11, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced the successful completion of enrollment in the SHIELD II Phase 3 trial for D-PLEX100 for the prevention of surgical site infections in patients undergoing abdominal colorectal surgery.
More Polypid Ltd News

Company Profile

PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform. Its products include D-PLEX, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX100 for the prevention of post-abdominal surgery incisional infection; BONYPID-1000, an antibiotic eluting ß tri-calcium phosphate granule for bone related infections applications; and BONYPID–500, an antibiotic eluting bone graft substitute that fills and reconstructs periodontal and oral/maxillofacial defects, while protecting from infections. PolyPid Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel.

Head office Israel
CEO Dikla Akselbrad
Employees 61
Founded 2008
Website www.polypid.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today